Motley Fool Australia

Telix Pharmaceuticals Ltd (ASX: TLX) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $1.12 billion
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 281.37 million
Earnings per share -0.175
Dividend per share N/A
Year To Date Return 7.67%
Earnings Yield N/A
Franking N/A

Telix Pharmaceuticals Ltd (ASX: TLX) Latest News

Businessman with hands on hips looks at share price chart with the words 'buy' and 'sell '

Top brokers name 3 ASX small cap shares to buy

More »

woman throwing arms up in celebration whilst looking at asx share price rise on laptop computer

Why the Telix (ASX:TLX) share price is storming 5% higher

More »

Young woman in yellow striped top with laptop raises arm in victory

3 ASX shares that helped this fund manager smash the market

More »

red arrow pointing down, falling share price

Why Ampol, Flight Centre, Syrah, & Telix shares are dropping lower

More »

asx share price falling represented by graph of paper plane trending down

Why the Telix (ASX:TLX) share price is dropping lower today

More »

asx share price growth represented by rocket flying up increasing bar chart.

How the Telix (ASX:TLX) share price roared over 150% in a year

More »

close up of man's eye looking through magnifying glass representing asx 200 share price on watch

The Telix (ASX:TLX) share price is on the move today. Here’s why.

More »

medical research

Telix (ASX:TLX) share price slips despite priority review status

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Telix Pharmaceuticals Ltd (ASX: TLX)

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 Apr 2021 $3.97 $-0.10 -2.46% 641,047 $4.08 $4.08 $3.92
15 Apr 2021 $4.07 $0.01 0.25% 257,055 $4.17 $4.20 $4.03
14 Apr 2021 $4.06 $0.02 0.50% 487,088 $4.15 $4.25 $4.06
13 Apr 2021 $4.04 $-0.03 -0.74% 233,761 $4.07 $4.17 $4.02
12 Apr 2021 $4.07 $-0.18 -4.24% 465,510 $4.20 $4.25 $4.07
09 Apr 2021 $4.25 $0.06 1.43% 297,054 $4.26 $4.29 $4.19
08 Apr 2021 $4.19 $0.00 0.00% 697,956 $4.21 $4.29 $4.14
07 Apr 2021 $4.19 $-0.39 -8.52% 1,102,031 $4.65 $4.74 $4.13
06 Apr 2021 $4.58 $0.10 2.23% 859,556 $4.55 $4.65 $4.43
01 Apr 2021 $4.48 $0.20 4.67% 616,820 $4.39 $4.53 $4.35
31 Mar 2021 $4.28 $-0.05 -1.15% 690,656 $4.46 $4.54 $4.27
30 Mar 2021 $4.33 $-0.07 -1.59% 312,360 $4.41 $4.48 $4.33
29 Mar 2021 $4.40 $-0.10 -2.22% 204,380 $4.55 $4.55 $4.37
26 Mar 2021 $4.50 $0.00 0.00% 197,792 $4.50 $4.54 $4.44
25 Mar 2021 $4.50 $-0.01 -0.22% 435,002 $4.55 $4.56 $4.40
24 Mar 2021 $4.51 $-0.21 -4.45% 780,638 $4.72 $4.80 $4.42
23 Mar 2021 $4.72 $0.19 4.19% 1,573,668 $4.50 $4.77 $4.50
22 Mar 2021 $4.53 $0.19 4.38% 1,055,179 $4.30 $4.58 $4.28
19 Mar 2021 $4.34 $-0.02 -0.46% 7,345,085 $4.25 $4.41 $4.20
18 Mar 2021 $4.36 $0.15 3.56% 987,554 $4.29 $4.43 $4.26
17 Mar 2021 $4.21 $0.06 1.45% 1,307,035 $4.15 $4.33 $4.12
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
02 Nov 2020 Oliver Buck Exercise 165 $140,530
02 Nov 2020 Oliver Buck Buy 165 $140,530
12 May 2020 Christian Behrenbruch Issued 200 $294,000


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Harry Kevin McCann Non-Executive Chairman,Non-Executive Director Sep 2017
Ms Jann E Skinner Non-Executive Director Jun 2018
Dr Christian Peter Behrenbruch Chief Executive Officer,Managing Director Jan 2017
Dr Andreas Kluge Non-Executive Director Jan 2017
Mr Oliver Buck Non-Executive Director Jan 2017
Dr Mark Alexander Nelson Non-Executive Director Sep 2017
Ms Melanie Farris Chief Governance & Risk Officer,Company Secretary Mar 2017
David Cade Chief Business Officer & Head of Investor Relations
Melanie Farris Chief Governance & Risk Officer,Company Secretary
Colin Hayward Chief Medical Officer
Jonathan Barlow General Counsel
Margaret Haarhoff Global Director of People & Culture
Michael Larcom Global Director of Quality
Doug Cubbin Group Chief Financial Officer
Gabriel Liberatore Group Chief Operating Officer
Ludovic Wouters President, Telix Europe
Shintaro Nishimura President, Telix Japan
Bernard Lambert President, Telix US
Tracey Brown SVP Global Clinical Operations
Sunil Kadam SVP Global Regulatory Affairs
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 37,477,609 13.37%
ELK River Holdings Pty Ltd 24,675,000 8.80%
Gnosis Verwaltungsgesellschaftm B H 24,675,000 8.80%
Grand Decade Developments Limited 20,947,181 7.47%
J P Morgan Nominees Australia Pty Limited 8,371,563 2.99%
UV Cap Gmbh & Co Kg 7,775,000 2.77%
BNP Paribas Noms Pty Ltd 6,904,087 2.46%
The Oncidium Foundation 6,470,392 2.31%
National Nominees Limited 6,361,306 2.27%
Citicorp Nominees Pty Limited 6,249,988 2.23%
Scintec Diagnostics Gmbh 4,312,151 1.54%
BNP Paribas Nominees Pty Ltd 3,782,218 1.35%
UBS Nominees Pty Ltd 3,029,153 1.08%
HSBC Custody Nominees (Australia) Limited A/C 2 2,843,462 1.01%
Jean Marc Le Doussal 2,750,000 0.98%
Ilusa Sprl 2,558,138 0.91%
Yelwac Pty Ltd 2,381,804 0.85%
Man Holdings Pty Ltd 2,238,750 0.80%
Telix Pharmaceuticals (Est) Pty Ltd 2,115,000 0.75%
Aglub Investments Pty Ltd 1,933,342 0.69%
Jean Francois Chatal 1,797,795 0.64%
Show more